The objective of this review was to overview published cost-of-illness (COI) studies of
epilepsy and their methodological approaches. Epilepsy imposes a substantial burden on …

Background Post-COVID syndrome (PCS) is an important sequela of COVID-19, characterised
by symptom persistence for >3 months, post-acute symptom development, and worsening …

Nationwide analyses of drug use can provide a prevalence estimate of the underlying disease
and can help in understanding the characteristics of treatment. This study aimed for such …

BACKGROUND: Restless Legs Syndrome (RLS) has a substantial impact on normal daily
activities. Because of the high prevalence it is necessary to evaluate the impact on the health-…

Purpose To evaluate long-term outcome of three years and treatment patterns of patients
suffering from severely drug-refractory epilepsy (SDRE). Methods This analysis was population-…

To investigate the health‐related quality of life (HrQoL) of adult patients with Gilles de la
Tourette's syndrome (GTS) in Germany. HrQoL was evaluated in 200 adult patients with GTS (…

In addition to medical treatment, deep brain stimulation has become an alternative therapeutic
option in advanced Parkinson's disease. High initial costs of surgery have to be weighted …

Neuromuscular disorders are rare diseases with a chronic and debilitating course. Unfortunately,
data on the health-related quality of life (HRQoL) in neuromuscular diseases are limited…

Previous studies have shown that amyloid β protein (Aβ), the essential molecule for the
formation of toxic oligomers and, subsequently, Alzheimer plaques, has been associated in vivo …

Objective To provide first data on inpatient costs and cost‐driving factors due to nonrefractory
status epilepticus ( NSE ), refractory status epilepticus ( RSE ), and super‐refractory status …